Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Assets Average (2017 - 2025)

Anaptysbio's Assets Average history spans 9 years, with the latest figure at $358.7 million for Q4 2025.

  • For Q4 2025, Assets Average fell 26.58% year-over-year to $358.7 million; the TTM value through Dec 2025 reached $358.7 million, down 26.58%, while the annual FY2025 figure was $424.1 million, 9.4% down from the prior year.
  • Assets Average reached $358.7 million in Q4 2025 per ANAB's latest filing, up from $344.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $634.1 million in Q1 2022 to a low of $344.2 million in Q3 2025.
  • Average Assets Average over 5 years is $483.4 million, with a median of $465.1 million recorded in 2023.
  • Peak YoY movement for Assets Average: surged 56.0% in 2022, then fell 26.58% in 2025.
  • A 5-year view of Assets Average shows it stood at $533.7 million in 2021, then increased by 15.13% to $614.4 million in 2022, then decreased by 23.53% to $469.9 million in 2023, then increased by 3.99% to $488.6 million in 2024, then dropped by 26.58% to $358.7 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Assets Average are $358.7 million (Q4 2025), $344.2 million (Q3 2025), and $378.7 million (Q2 2025).